$55 Million Gift to Penn is Aimed at Stopping Breast Cancer Before It Starts
Mindy Gray and her husband, Blackstone president Jon Gray, gave the money in honor of Mindy's sister Faith Basser.
Blackstone’s Gray Gives UPenn $55 Million for Cancer Prevention
Jon and Mindy Gray’s gift will fund an institute focused on early detection of breast, ovarian, pancreatic and prostate cancers.
$55 Million Gift Creates New “Cancer Interception” Institute at Penn’s Basser Center for BRCA to Stop Hereditary Cancers at the Earliest Stages
Funding for the Institute from Mindy and Jon Gray will propel early detection and prevention of breast, ovarian, pancreatic, and prostate cancers.
Study Shows High Rate of Actionable Mutations in Lung Cancer
Kara Maxwell, MD, PhD was invited as a discussant on research relating to germline genetic testing and whether it should be done for all lung cancer patients is probably a bit premature.
Breast Cancer Drug Trial Results in "Unheard-Of" Survival
Susan Domchek, MD, presented at ASCO on clinical trials of the experimental drug, Enhertu, that showed slowed tumor growth in breast cancer patients & extended life with advanced cancers.
Genetic testing: A life-saver for Black women and breast cancer
Dana Clark, MS, Basser Center genetic counselor, spoke about the value of genetic testing in cancer prevention, while dispelling myths associated with access and cost. Her patient, Kimyatta, shares her story and strong hereditary link to the disease.
UPenn Researchers Enrolling BRCA1/2 Carriers Into Inovio hTERT Cancer Vaccine Study
Susan Domchek, MD, Executive Director of the Basser Center, presented on a clinical trial assessing if a vaccine can prevent breast cancer patients with BRCA1/2 mutations from relapsing and prevent healthy people with mutations from developing cancer
A Universal Drug Target for Ovarian Cancer
Ronny Drapkin, MD, PhD, Director of the Penn Ovarian Cancer Research Center and Gynecologic Cancer Research in the Basser Center, shares his thoughts on the discovery of a blood vessel-promoting protein interaction found in ovarian tumors.
How A Genetic Test Saved This Black Woman’s Life
Ashley Dedmon shares her journey and how working with the Basser Center for the Black and BRCA Initiative has helped her spread awareness in educating younger generations.
UPenn Researchers Enrolling BRCA1/2 Carriers Into Inovio hTERT Cancer Vaccine Study
Susan Domchek, MD, Executive Director of the Basser Center, presents on a clinical trial assessing if a vaccine can prevent breast cancer patients with BRCA1/2 from relapsing and prevent healthy people with mutations from developing cancer.